Medical Cannabis Registered in Spain, but Patient Access Remains Delayed

Spain's first standardized medical cannabis preparations have been officially registered for over two months, yet hospitals have not begun acquiring or dispensing them to patients. This gap between regulatory approval and clinical implementation highlights ongoing challenges in the European medical cannabis rollout. The delay raises concerns for patients with conditions like chronic pain, epilepsy, and multiple sclerosis who could benefit from these treatments. Healthcare officials must clarify timelines and distribution protocols to ensure patients can access these medications. This situation reflects broader implementation barriers across European healthcare systems transitioning to regulated cannabis therapeutics.